⭐ High Impact

Low micromolar concentrations of the superoxide probe MitoSOX uncouple neural mitochondria and inhibit complex IV.

Roelofs Brian A, Ge Shealinna X, Studlack Paige E, Polster Brian M

📰 Free radical biology & medicine 📅 2015 📊 83 citations

Abstract

MitoSOX Red is a fluorescent probe used for the detection of mitochondrial reactive oxygen species by live cell imaging. The lipophilic, positively charged triphenylphosphonium moiety within MitoSOX concentrates the superoxide-sensitive dihydroethidium conjugate within the mitochondrial matrix. Here we investigated whether common MitoSOX imaging protocols influence mitochondrial bioenergetic function in primary rat cortical neurons and microglial cell lines. MitoSOX dose-dependently uncoupled neuronal respiration, whether present continuously in the assay medium or washed following a ten minute loading protocol. Concentrations of 5-10μM MitoSOX caused severe loss of ATP synthesis-linked respiration. Redistribution of MitoSOX to the cytoplasm and nucleus occurred concomitant to mitochondrial uncoupling. MitoSOX also dose-dependently decreased the maximal respiration rate and this impairment could not be rescued by delivery of a complex IV specific substrate, revealing complex IV inhibition. As in neurons, loading microglial cells with MitoSOX at low micromolar concentrations resulted in uncoupled mitochondria with reduced respiratory capacity whereas submicromolar MitoSOX had no adverse effects. The MitoSOX parent compound dihydroethidium also caused mitochondrial uncoupling and respiratory inhibition at low micromolar concentrations. However, these effects were abrogated by pre-incubating dihydroethidium with cation exchange beads to remove positively charged oxidation products, which would otherwise by sequestered by polarized mitochondria. Collectively, our results suggest that the matrix accumulation of MitoSOX or dihydroethidium oxidation products causes mitochondrial uncoupling and inhibition of complex IV. Because MitoSOX is inherently capable of causing severe mitochondrial dysfunction with the potential to alter superoxide production, its use therefore requires careful optimization in imaging protocols.

🔬 Techniques

🔭 Microscopes

💻 Software

✨ Fluorophores

🧪 Sample Preparation

🔬 Cell Lines

🏭 Microscope Brands

Zeiss

🧪 Reagent Suppliers

💻 Software Details

Image Acquisition:
IN Cell

🏛️ Research Organizations (ROR)

Affiliated research institutions:

📋 Methods

✔ Verified methods section 895 words Read on PMC ↗

Materials All cell culture supplies, as well as MitoSOX™ Red mitochondrial superoxide detection reagent, were from Invitrogen (Grand Island, NY). All other reagents were from Sigma-Aldrich (St. Louis, MO). Pyruvate was made fresh from powder (sodium salt, Sigma-Aldrich #P2256) prior to each experiment. Other reagents were diluted from pH-adjusted stocks stored at -20°C. Artificial cerebrospinal fluid (aCSF) assay medium consisting of NaCl (120 mM), KCl (3.5 mM), CaCl 2 (1.3 mM), KH 2 PO 4 (0.4 mM), MgCl 2 (1 mM), and HEPES (5 mM) was pH-adjusted to 7.4 and stored at -20°C. Glucose (15 mM) and 4 mg/ml fatty acid-free bovine serum album (Sigma-Aldrich, catalogue #A6003) were added to aCSF on the day of the experiment.

Preparation of Primary Cortical Neurons

Primary rat cortical neurons from E18 rat cortices were prepared by enzymatic trypsin dissociation [ 24 , 25 ] and cells were cultured and plated for analysis by Seahorse Bioscience XF24 microplate-based respirometry as previously described [ 26 ]. Cytosine arabinofuranoside (5 μM) added at 4 days in vitro (DIV) was used to inhibit glial proliferation. Neurons were maintained at 37°C in a humidified atmosphere of 95% air/5% CO 2 and used for experiments at DIV 10-14. All procedures were approved by the University of Maryland Institutional Animal Care and Use Committee (IACUC protocol #1109008 and #0813014) and were in agreement with the NIH Guide for the Care and Use of Laboratory Animals. O 2 consumption rate (OCR) measurements O 2 consumption measurements were made using an XF24 Extracellular Flux Analyzer (Seahorse Bioscience) as described [ 26 , 27 ]. Briefly, cell culture medium was removed, cells were washed once with 1 ml aCSF assay medium supplemented with glucose (15 mM) and fatty acid-free bovine serum albumin (4 mg/ml), and cells were then incubated in 675 μl of aCSF in a CO 2 -free incubator. For MitoSOX pre-treatments, cells were incubated with or without 0.1% dimethyl sulfoxide vehicle or MitoSOX treatments (0.2 to 10 μM). Treatments were either removed after 10 minutes of incubation or maintained throughout the experiment as indicated. In other experiments, cells were acutely exposed to MitoSOX via injection. MitoSOX and other drugs of interest were loaded into reagent delivery chambers a, b, c, d in a 75 μl volume and injected sequentially at 10×, 11×, 12×, and 13× the final working concentration, respectively. Each assay consisted of cycles of 3 min mix, 3 min wait, and 2 min measure, and was performed at 37°C. In experiments where the exogenous electron donor N,N,N′N′-tetramethyl-p-phenylenediamine (TMPD, 0.1 mM) was used in combination with ascorbate (10 mM), the same concentrations of these chemicals were injected in a blank well on the XF24 plate at the same time the compounds were added to cells. The OCR in the blank well which contained aCSF but no cells was used to correct cellular OCR measurements for O 2 consumption due to chemical auto-oxidation following TMPD plus ascorbate treatments.

Show full methods section

Materials All cell culture supplies, as well as MitoSOX™ Red mitochondrial superoxide detection reagent, were from Invitrogen (Grand Island, NY). All other reagents were from Sigma-Aldrich (St. Louis, MO). Pyruvate was made fresh from powder (sodium salt, Sigma-Aldrich #P2256) prior to each experiment. Other reagents were diluted from pH-adjusted stocks stored at -20°C. Artificial cerebrospinal fluid (aCSF) assay medium consisting of NaCl (120 mM), KCl (3.5 mM), CaCl 2 (1.3 mM), KH 2 PO 4 (0.4 mM), MgCl 2 (1 mM), and HEPES (5 mM) was pH-adjusted to 7.4 and stored at -20°C. Glucose (15 mM) and 4 mg/ml fatty acid-free bovine serum album (Sigma-Aldrich, catalogue #A6003) were added to aCSF on the day of the experiment.

Preparation of Primary Cortical Neurons

Primary rat cortical neurons from E18 rat cortices were prepared by enzymatic trypsin dissociation [ 24 , 25 ] and cells were cultured and plated for analysis by Seahorse Bioscience XF24 microplate-based respirometry as previously described [ 26 ]. Cytosine arabinofuranoside (5 μM) added at 4 days in vitro (DIV) was used to inhibit glial proliferation. Neurons were maintained at 37°C in a humidified atmosphere of 95% air/5% CO 2 and used for experiments at DIV 10-14. All procedures were approved by the University of Maryland Institutional Animal Care and Use Committee (IACUC protocol #1109008 and #0813014) and were in agreement with the NIH Guide for the Care and Use of Laboratory Animals. O 2 consumption rate (OCR) measurements O 2 consumption measurements were made using an XF24 Extracellular Flux Analyzer (Seahorse Bioscience) as described [ 26 , 27 ]. Briefly, cell culture medium was removed, cells were washed once with 1 ml aCSF assay medium supplemented with glucose (15 mM) and fatty acid-free bovine serum albumin (4 mg/ml), and cells were then incubated in 675 μl of aCSF in a CO 2 -free incubator. For MitoSOX pre-treatments, cells were incubated with or without 0.1% dimethyl sulfoxide vehicle or MitoSOX treatments (0.2 to 10 μM). Treatments were either removed after 10 minutes of incubation or maintained throughout the experiment as indicated. In other experiments, cells were acutely exposed to MitoSOX via injection. MitoSOX and other drugs of interest were loaded into reagent delivery chambers a, b, c, d in a 75 μl volume and injected sequentially at 10×, 11×, 12×, and 13× the final working concentration, respectively. Each assay consisted of cycles of 3 min mix, 3 min wait, and 2 min measure, and was performed at 37°C. In experiments where the exogenous electron donor N,N,N′N′-tetramethyl-p-phenylenediamine (TMPD, 0.1 mM) was used in combination with ascorbate (10 mM), the same concentrations of these chemicals were injected in a blank well on the XF24 plate at the same time the compounds were added to cells. The OCR in the blank well which contained aCSF but no cells was used to correct cellular OCR measurements for O 2 consumption due to chemical auto-oxidation following TMPD plus ascorbate treatments.

MitoSOX Imaging

Primary rat cortical neurons were plated on 2 or 4-well chamber slides (model 1 German borosilicate; Lab-Tek) at a density of either 250,000 (2-well) or 125,000 neurons (4-well). Neurons were cultured to DIV 10, and then exposed to two different imaging paradigms for MitoSOX. In the first paradigm, half of the culture medium was removed and replaced with medium containing 200 nM MitoTracker Green (for a final concentration of 100 nM), 20 μM Hoechst (for a final of 10 μM) and either 400 nM, 2 μM, 10 μM or 20 μM MitoSOX (to obtain final concentrations of 200 nM, 1 μM, 5 μM or 10 μM, respectively). Following a 10 minute incubation, neurons were then washed with dye-free aCSF three times and then immediately imaged with a Zeiss ApoTome- and AxioCamMRm Rev.3 camera-equipped AxioObserver Z1 inverted microscope (Zeiss MicroImaging), using a 100×/1.4 Plan-Apochromat objective lens. In the second paradigm, the culture medium was removed and replaced with aCSF containing 10 μM Hoechst and 100 nM MitoTracker Green. Following a 10 min incubation, neurons were then selected for live-cell imaging based on healthy tubular mitochondrial morphology and images were captured at 2 minute intervals. Exposure times were 50 ms for MitoTracker Green (using an emission wavelength of 524 nm), 250 ms for Hoechst (using an emission wavelength of 455 nm) and 25 ms for MitoSOX (using an emission wavelength of 572 nm). Following acquisition of the 6 th image (10 minutes after the initial starting baseline), FCCP was added to the medium at a final concentration of 5 μM. Following the 8 th image, MitoSOX was added to the medium to a final concentration of 10 μM and the subcellular MitoSOX distribution was imaged for 30 minutes.

Materials All cell culture supplies, as well as MitoSOX™ Red mitochondrial superoxide detection reagent, were from Invitrogen (Grand Island, NY). All other reagents were from Sigma-Aldrich (St. Louis, MO). Pyruvate was made fresh from powder (sodium salt, Sigma-Aldrich #P2256) prior to each experiment. Other reagents were diluted from pH-adjusted stocks stored at -20°C. Artificial cerebrospinal fluid (aCSF) assay medium consisting of NaCl (120 mM), KCl (3.5 mM), CaCl 2 (1.3 mM), KH 2 PO 4 (0.4 mM), MgCl 2 (1 mM), and HEPES (5 mM) was pH-adjusted to 7.4 and stored at -20°C. Glucose (15 mM) and 4 mg/ml fatty acid-free bovine serum album (Sigma-Aldrich, catalogue #A6003) were added to aCSF on the day of the experiment.

📊 Figures

Fig. 1

Low micromolar MitoSOX causes uncoupling and impairment of uncoupled respiration in neurons. A. Primary rat cortical neurons were treated with vehicle control (con, filled circles) or MitoSOX at the i...

Fig. 2

Low micromolar concentrations of MitoSOX show non-mitochondrial localization. In A, primary rat cortical neurons were incubated with 100 nM MitoTracker Green (green), 10 u03bcM Hoechst (blue) and eith...

Fig. 3

Mitochondrial matrix accumulation is required for MitoSOX inhibition of uncoupled respiration. In A , primary rat cortical neurons were treated with FCCP plus pyruvate (FCCP+pyr, 5 u03bcM and 10 mM, r...

Fig. 4

Mitochondrial localization of MitoSOX requires membrane potential. In A , primary rat cortical neurons were incubated with 100 nM MitoTracker green and 10 u03bcM Hoechst for 10 min. Candidate neurons ...

Fig. 5

Prevention of dihydroethidium-induced uncoupling and impairment of maximal respiration by removal of charged oxidation products using cation exchange beads. A. Primary rat cortical neurons were treate...

Fig. 6

MitoSOX impairs both complex I- and complex II-dependent ADP-stimulated respiration. A. Primary rat cortical neurons were treated with vehicle control (con, filled circles) or MitoSOX (10 u03bcM, open...

Fig. 7

Complex IV substrate fails to rescue MitoSOX impaired oxygen consumption. Primary rat cortical neurons were treated with vehicle control (con, filled circles) or MitoSOX (10 u03bcM, open circles) afte...

Fig. 8

Low micromolar MitoSOX causes mitochondrial bioenergetic dysfunction in microglial cells. Rat HAPI (A) or mouse BV2 (B) microglial cells were treated with vehicle control (con, filled circles) or Mito...

Figure images are served from the NIH/NLM PubMed Central Open Access Subset or Europe PMC; copyright remains with the publishers and authors.

🏛️ Imaging Facility

🏛️ Ministry of Defence

💬 Discussion

0 comments

No comments yet. Be the first to start a discussion!

Leave a Comment

MicroHub Assistant